Compare H & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | H | MEDP |
|---|---|---|
| Founded | 1957 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8B | 17.2B |
| IPO Year | 2009 | 2016 |
| Metric | H | MEDP |
|---|---|---|
| Price | $170.06 | $614.45 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 25 | 14 |
| Target Price | $195.96 | ★ $595.92 |
| AVG Volume (30 Days) | ★ 710.3K | 229.7K |
| Earning Date | 10-29-2026 | 10-21-2026 |
| Dividend Yield | ★ 0.36% | N/A |
| EPS Growth | N/A | ★ 20.98 |
| EPS | 1.53 | ★ 8.53 |
| Revenue | ★ $4,685,000,000.00 | N/A |
| Revenue This Year | $106.37 | $12.72 |
| Revenue Next Year | $8.26 | $6.33 |
| P/E Ratio | $110.27 | ★ $73.75 |
| Revenue Growth | ★ 5.78 | N/A |
| 52 Week Low | $134.18 | $373.00 |
| 52 Week High | $206.86 | $677.90 |
| Indicator | H | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 61.40 | 51.43 |
| Support Level | $155.49 | $570.70 |
| Resistance Level | $173.71 | $634.72 |
| Average True Range (ATR) | 4.09 | 19.38 |
| MACD | 1.69 | -0.05 |
| Stochastic Oscillator | 72.24 | 43.83 |
Hyatt is an operator of owned (2% of total rooms) and managed and franchised (98%) properties across about 35 upscale luxury brands, which include vacation brands (Apple Leisure Group, Hyatt Ziva, and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, the wellness brand Miraval, and the midscale extended-stay brand Studios. Hyatt acquired Two Roads Hospitality in 2018 and Apple Leisure Group in 2021. Regional exposure, as a percentage of total rooms, is 45% for the US, 31% for the rest of the world, and 24% for Asia-Pacific.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.